1. Home
  2. MDGL vs HLI Comparison

MDGL vs HLI Comparison

Compare MDGL & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$486.83

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$138.79

Market Cap

10.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
HLI
Founded
2011
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
10.4B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
MDGL
HLI
Price
$486.83
$138.79
Analyst Decision
Strong Buy
Buy
Analyst Count
12
7
Target Price
$674.45
$194.29
AVG Volume (30 Days)
284.2K
708.0K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
1.54%
EPS Growth
41.32
6.87
EPS
N/A
6.22
Revenue
$180,133,000.00
$2,617,516,000.00
Revenue This Year
$58.39
$13.77
Revenue Next Year
$48.55
$12.10
P/E Ratio
N/A
$22.26
Revenue Growth
N/A
9.55
52 Week Low
$275.00
$134.41
52 Week High
$615.00
$211.78

Technical Indicators

Market Signals
Indicator
MDGL
HLI
Relative Strength Index (RSI) 42.66 30.97
Support Level $461.99 $135.21
Resistance Level $502.97 $143.69
Average True Range (ATR) 21.60 4.08
MACD -6.10 -1.26
Stochastic Oscillator 37.40 18.34

Price Performance

Historical Comparison
MDGL
HLI

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

Share on Social Networks: